AB
Autoimmunity Biologic Solutions Inc.
SEC filingBiotechnology · Houston, TX
Amount raised$3.2Msold at filing
Total offering$3.2M
Investors in the raise15count reported to the SEC
FiledMay 6, 2026first sale Nov 8, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jimmy LuDirector
Brock ReeveDirector
Gaddiel Galarza-MunozExecutive Officer
Mariano Garcia-BlancoDirector
Eugene WilliamsExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.